skip to main content

ProfessionalsOliver Marcuse

Oliver Marcuse
Partner

Tel: +44-20-7601-8733
Mob: +44 7386-666737
omarcuse@paulweiss.com

Tel: +44-20-7601-8733
Mob: +44 7386-666737
omarcuse@paulweiss.com
London

20 Air Street
London, United Kingdom W1B 5AN

+ vCard ADD TO CONTACTS
Education 
Bar Admissions 
Education 
Bar Admissions 

A partner in the Mergers & Acquisitions and Private Equity Groups, Oliver Marcuse advises leading international private equity firms and portfolio companies on complex cross-border transactions. His practice encompasses a wide range of matters, including leveraged buyouts, acquisitions and disposals, GP-led M&A and secondaries transactions, mergers, joint ventures, co-investments, IPOs, restructurings and refinancings.

Oliver's expertise spans multiple sectors, including healthcare, infrastructure, consumer, industrials, logistics and technology. He has worked on some of the most significant cross-border private equity deals in Europe, representing major sponsors and their portfolio companies. Recognized for his talent in the field, Oliver was named a Private Equity Rising Star 2022 by Law.com.

With extensive experience gained through his work with top-tier private equity firms, including secondments at CVC and Cinven, Oliver brings a deep understanding of the European private equity landscape to his practice.

EXPERIENCE

Oliver's notable representations have included:

  • Cinven in a variety of transactions including in its:
    • acquisition of JLA from Hg Capital
    • £2.3 billion disposal of Amdipharm Mercury Company (AMCo) to Concordia Healthcare Corporation
    • €1.3 billion acquisition of Labco
    • €1.7 billion acquisition of Synlab from BC Partners and its combination with Labco and subsequent €5.9 billion IPO
    • Fund VI sale of group.ONE to Fund VII, in partnership with OTPP
    • US$2 billion acquisition of Ceramtec
  • Cinven and Novo Holdings in the €2.8 billion sale of Envirotainer to EQT and Mubadala
  • Cinven, Permira and Mid Europa on the acquisition, and subsequent €9.8 billion IPO, of allegro.eu
  • CVC in its £1.1 billion acquisition of leading consumer finance and tech business, NewDay, with Cinven
  • BlackRock Private Equity Partners on a P2P co-investment
  • Blackstone in its $640 million acquisition of a majority stake in The Office Group
  • Onex in its acquisition of Independent Clinical Services from TowerBrook Capital Partners
  • Middleground Capital in a variety of transactions including in its:
    • acquisition of Xtrac from Inflexion
    • acquisition of majority ownership stake in Integral Powertrain
  • DWS Group in the sale of its Private Equity Solutions business to Brookfield Asset Management
  • The founders of DRC Capital in its sale to Savills IM
  • The shareholders of WSH in its £780 million partnership with Clayton, Dubilier & Rice
  • Apax in its:
    • £1.9 billion sale of New Look to Brait, with Permira
    • £677 million acquisition of EVRY ASA
  • ICGSE in its GP-led investment in certain assets of Mid Europa Funds III and IV
  • CPPIB and Hermes in its £1.6 billion acquisition of a minority stake in Associated British Ports

© 2024 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy